- Home
- MFA vs ATRC Comparison
MFA vs ATRC Comparison
Compare MFA & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFA
- ATRC
- Stock Information
- Founded
- MFA 1997
- ATRC 2000
- Country
- MFA United States
- ATRC United States
- Employees
- MFA N/A
- ATRC N/A
- Industry
- MFA Real Estate Investment Trusts
- ATRC Medical/Dental Instruments
- Sector
- MFA Real Estate
- ATRC Health Care
- Exchange
- MFA Nasdaq
- ATRC Nasdaq
- Market Cap
- MFA 980.3M
- ATRC 1.6B
- IPO Year
- MFA N/A
- ATRC 2005
- Fundamental
- Price
- MFA $9.36
- ATRC $30.72
- Analyst Decision
- MFA Buy
- ATRC Strong Buy
- Analyst Count
- MFA 8
- ATRC 10
- Target Price
- MFA $11.86
- ATRC $49.50
- AVG Volume (30 Days)
- MFA 1.5M
- ATRC 399.6K
- Earning Date
- MFA 08-06-2025
- ATRC 07-29-2025
- Dividend Yield
- MFA 15.38%
- ATRC N/A
- EPS Growth
- MFA N/A
- ATRC N/A
- EPS
- MFA 0.99
- ATRC N/A
- Revenue
- MFA $292,245,000.00
- ATRC $480,076,000.00
- Revenue This Year
- MFA N/A
- ATRC $14.63
- Revenue Next Year
- MFA $14.73
- ATRC $12.62
- P/E Ratio
- MFA $9.45
- ATRC N/A
- Revenue Growth
- MFA 52.95
- ATRC 15.79
- 52 Week Low
- MFA $7.85
- ATRC $20.20
- 52 Week High
- MFA $13.45
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- MFA 42.80
- ATRC 39.22
- Support Level
- MFA $9.51
- ATRC $31.00
- Resistance Level
- MFA $9.73
- ATRC $32.44
- Average True Range (ATR)
- MFA 0.19
- ATRC 1.03
- MACD
- MFA -0.02
- ATRC -0.09
- Stochastic Oscillator
- MFA 17.27
- ATRC 8.65
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.